Further evidence for differential regulation of follicle-stimulating hormone (FSH) and luteinizing hormone (LH): increased FSH and decreased LH levels in a patient with familial pure gonadal dysgenesis.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2399467)

Published in Postgrad Med J on November 01, 1992

Authors

V Popovic1, D Micic, S Damjanovic, L Calovic, Z Rolovic, A Mijovic, M Petakov, D Manojlovic, J Micic

Author Affiliations

1: Institute of Endocrinology, University Clinical Center, School of Medicine, Belgrade, Yugoslavia.

Articles cited by this

Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90

Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats. Endocrinology (1988) 1.02

Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. Science (1986) 0.99

Pure gonadal dysgenesis (type XX). Report on a family with four affected sibs. Hum Genet (1977) 0.92

Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men. J Clin Endocrinol Metab (1986) 0.91

Acute and chronic effects of hypothalamic lesions on the release of FSH, LH and prolactin in intact and castrated rats. Endocrinology (1972) 0.89

Gonadal regulation of gonadotropin subunit gene expression: evidence for regulation of follicle-stimulating hormone-beta messenger ribonucleic acid by nonsteroidal hormones in female rats. Endocrinology (1990) 0.88

Hypersecretion of follicle-stimulating hormone (FSH) after ovariectomy of hypophysectomized, pituitary-grafted rats: implications for local regulatory control of FSH. Endocrinology (1991) 0.85

Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone. J Clin Endocrinol Metab (1991) 0.83

Top concentrations of dynorphin-like immunoreactivity in fractions of rat anterior pituitary cells enriched in gonadotrophs. Life Sci (1986) 0.81

Articles by these authors

Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) (2008) 2.51

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet (2000) 2.11

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci (2007) 1.81

Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf) (1998) 1.75

The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood (2000) 1.46

A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin Endocrinol (Oxf) (2002) 1.39

Belgrade virus: a new hantavirus causing severe hemorrhagic fever with renal syndrome in Yugoslavia. J Infect Dis (1992) 1.09

Transfusion-transmitted malaria: current donor selection guidelines are not sufficient. Vox Sang (2005) 1.04

J/psi production in Indium-Indium collisions at 158 GeV/nucleon. Phys Rev Lett (2007) 0.95

The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability. Bone Marrow Transplant (1999) 0.94

Late thrombosis of the Björk-Shiley tilting disc valve in the tricuspid position. Thrombolytic treatment with streptokinase. J Thorac Cardiovasc Surg (1986) 0.93

Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia (2002) 0.92

Differentially expressed genes in adult familial myelodysplastic syndromes. Leukemia (2004) 0.89

'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins. Br J Haematol (1998) 0.89

Leptin and the pituitary. Pituitary (2002) 0.89

First measurement of the rho spectral function in high-energy nuclear collisions. Phys Rev Lett (2006) 0.87

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol (1997) 0.87

Megakaryocytopoiesis in experimentally induced immune thrombocytopenia. Blood (1970) 0.87

Evidence for radial flow of thermal dileptons in high-energy nuclear collisions. Phys Rev Lett (2008) 0.85

Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome. Acta Paediatr (2003) 0.85

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience. Bone Marrow Transplant (2010) 0.85

Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab (2003) 0.85

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab (1995) 0.84

Epidemiology of Trichinella infection in the horse: the risk from animal product feeding practices. Vet Parasitol (2004) 0.84

The effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen. Physiol Res (2006) 0.83

Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study. J Obes (2010) 0.82

Effect of IL-17 on in vitro hematopoietic progenitor cells growth and cytokine release in normal and post-irradiated murine bone marrow. Growth Factors (2001) 0.82

Prediction of fetal macrosomia with ultrasound parameters and maternal glycemic controls in gestational diabetes mellitus. Clin Exp Obstet Gynecol (2012) 0.81

Comparative studies of the viability of human platelets stored at 4 C in plastic and glass containers. Transfusion (1967) 0.81

Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. J Steroid Biochem (1988) 0.80

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. J Endocrinol Invest (2007) 0.80

In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice. Cell Prolif (2004) 0.79

Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diabetes (2011) 0.79

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol Dis (2012) 0.78

Cardiac autonomic control in patients with myasthenia gravis and thymoma. J Neurol Sci (2011) 0.77

Abnormal megakaryocytopoiesis in the Belgrade laboratory rat. Blood (1985) 0.77

The absence of the vomer in the first and early second trimester of pregnancy - a new marker of trisomy 21 and trisomy 13. Ultraschall Med (2011) 0.77

Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa. J Endocrinol Invest (2004) 0.77

Control and function of the GH-IGF-I axis in obesity. Eat Weight Disord (2001) 0.76

Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation. Bone Marrow Transplant (2005) 0.76

Discordance between growth hormone responses after growth hormone-releasing hormone (GHRH) and insulin hypoglycemia in ectopic GHRH syndrome. Endocrinol Exp (1990) 0.76

Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency. Growth Horm IGF Res (2013) 0.76

Systolic right ventricular adaptive changes in athletes as predictors of the maximal functional capacity: a pulsed tissue Doppler study. J Sports Med Phys Fitness (2011) 0.75

Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Br J Haematol (2000) 0.75

Collection strategies and cryopreservation of umbilical cord blood. Transfus Med (2007) 0.75

Do CD34+ cell counts predict haemopoietic recovery after autologous blood stem cell transplantation (ABSCT)? Br J Haematol (1995) 0.75

Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia. Balkan J Med Genet (2011) 0.75

Acute sterile inflammation--correlation between cellular changes and extramedullary-produced regulators in vivo. Ann Hematol (1993) 0.75

ACTH and cortisol responses to ghrelin and desmopressin in patients with Cushing's disease and adrenal enlargement. J Endocrinol Invest (2010) 0.75

Cerebral microvessels as mediators of cerebral transport. Adv Neurol (1978) 0.75

Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration. J Endocrinol Invest (1991) 0.75

Thrombopoietin stimulation of megakaryocytopoiesis in agar culture. Prog Clin Biol Res (1986) 0.75

[Hematopoietic growth factors--physiology and therapeutic use]. Vojnosanit Pregl (1997) 0.75

Cytochemical & ultrastructural alteration of cytoplasmic granules of rat peripheral blood neutrophils induced by chronic alcoholism & malnutrition. Indian J Med Res (1999) 0.75

Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes. Transfusion (2003) 0.75

Leptonic and charged kaon decay modes of the phi meson measured in heavy-ion collisions at the CERN super proton synchrotron. Phys Rev Lett (2006) 0.75

[Congenital elliptocytosis]. Srp Arh Celok Lek (1975) 0.75

Cepstral distance measures of hormone concentration time series. Stud Health Technol Inform (1998) 0.75

Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumors. Neuroendocrinology (1993) 0.75

Hemoglobin Beograd or alpha 2 beta 2 121 Glu-Val (GH4). Biochim Biophys Acta (1973) 0.75

Megakaryocytopoiesis in splenectomized and 'hypersplenic' rats. Br J Haematol (1970) 0.75

The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors. Neoplasma (2010) 0.75

First results on angular distributions of thermal dileptons in nuclear collisions. Phys Rev Lett (2009) 0.75

The effects of thrombopoietic activity of rabbit plasma fractions on megakaryocytopoiesis in agar cultures. Exp Hematol (1988) 0.75

Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation. Vojnosanit Pregl (2000) 0.75

The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors. Thyroid (1998) 0.75

Sweet's syndrome associated with inversion of chromosome 3q in a patient with refractory anemia. Eur J Haematol (1992) 0.75

Evaluation of pituitary GH reserve with GHRP-6. J Pediatr Endocrinol Metab (1996) 0.75

[Chronic myeloid leukemia with 2 Philadelphia (Ph') chromosomes in bone marrow cells]. Lijec Vjesn (1970) 0.75

Growth hormone secretagogues in pathological states: diagnostic implications. Acta Paediatr Suppl (1997) 0.75

Case report of hypopituitarism with suspected syndrome of inappropriate VP secretion (SIADH) due to a large aneurysm of the internal carotid in the sellar region. J Endocrinol Invest (2003) 0.75

Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. J Clin Endocrinol Metab (1994) 0.75

VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. Clin Oncol (R Coll Radiol) (1995) 0.75

[Endoscopic ultrasonography (EUS) in preoperative localization of neuroendocrine tumors (NET) of the pancreas]. Acta Chir Iugosl (2005) 0.75

Dysmegakaryocytopoiesis and thrombocytosis in a patient with acute myelomonocytic leukemia and long evolution. Haematologia (Budap) (1991) 0.75

Single dose of filgrastim (rhG-CSF) to predict mobilisation of haemopoietic progenitors in patients with haematological malignancies. Bone Marrow Transplant (1995) 0.75

Loss of gender difference in serum leptin levels and its slow recovery after successful surgery for Leydig cell tumours in two virilized females. Clin Endocrinol (Oxf) (2001) 0.75

Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT). Bone Marrow Transplant (1997) 0.75

GH response to growth hormone releasing hormone and hypoglycaemia is unaltered by high endogenous plasma calcitonin levels in patients with medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1991) 0.75

Studies of platelet adhesiveness with reference to platelet age. Scand J Haematol (1969) 0.75

The in vivo effect of liposomes on hematopoiesis. Drug Dev Ind Pharm (1999) 0.75

Two karyotypically unrelated clones with the t(5;17) and deletion of 5q in myelodysplastic syndrome. Cancer Genet Cytogenet (1992) 0.75

Effects of treatment with interleukin-1 receptor antagonist on endogenous interleukin-1 levels in normal and irradiated mice. Physiol Res (2000) 0.75

Characteristics of rat megakaryocyte colonies and their progenitors in agar culture. Exp Hematol (1985) 0.75

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. Clin Endocrinol (Oxf) (1998) 0.75

Serum leptin and insulin concentrations in patients with insulinoma before and after surgery. Eur J Endocrinol (1998) 0.75

Pituitary enlargement due to primary hypothyroidism: growth hormone response to GHRH, GHRP-6 and GHRH plus GHRP-6. J Pediatr Endocrinol Metab (1997) 0.75